Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Doherty

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Annals of Surgery|May 1, 1995
Prolongation of skin allografts by recombinant tumor necrosis factor and interleukin-1G L Parenteau, G M Doherty, G R Peplinski, et al.
Surgery|December 1, 1990
Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndromeG M Doherty, L K Nieman, G B Cutler, et al.
Journal of the American College of Surgeons|July 1, 1997
Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancyM P Callery, S M Strasberg, G M Doherty, et al.
The Journal of Surgical Research|June 1, 1992
Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitisJ R Lange, H R Alexander, M J Merino, et al.
Annals of Surgical Oncology|March 1, 1996
Role of endogenous interferon gamma in murine tumor growth and tumor necrosis factor alpha antitumor efficacyG M Doherty, H R Alexander, M J Merino, et al.
Cancer Research|May 1, 1991
The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexiaH N Langstein, G M Doherty, D L Fraker, et al.
Annals of Surgical Oncology|June 1, 1997
Underlying pathology in mammary Paget's diseaseJ H Yim, M R Wick, G W Philpott, et al.
The Journal of Experimental Medicine|April 1, 1991
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in miceH R Alexander, G M Doherty, C M Buresh, et al.
Surgery|August 1, 1991
Pentoxifylline suppression of tumor necrosis factor gene transcriptionG M Doherty, J C Jensen, H R Alexander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic miceJ H Yim, S J Wu, M J Casey, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Annals of Surgery|May 1, 1995
Prolongation of skin allografts by recombinant tumor necrosis factor and interleukin-1G L Parenteau, G M Doherty, G R Peplinski, et al.
Surgery|December 1, 1990
Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndromeG M Doherty, L K Nieman, G B Cutler, et al.
Journal of the American College of Surgeons|July 1, 1997
Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancyM P Callery, S M Strasberg, G M Doherty, et al.
The Journal of Surgical Research|June 1, 1992
Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitisJ R Lange, H R Alexander, M J Merino, et al.
Annals of Surgical Oncology|March 1, 1996
Role of endogenous interferon gamma in murine tumor growth and tumor necrosis factor alpha antitumor efficacyG M Doherty, H R Alexander, M J Merino, et al.
Cancer Research|May 1, 1991
The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexiaH N Langstein, G M Doherty, D L Fraker, et al.
Annals of Surgical Oncology|June 1, 1997
Underlying pathology in mammary Paget's diseaseJ H Yim, M R Wick, G W Philpott, et al.
The Journal of Experimental Medicine|April 1, 1991
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in miceH R Alexander, G M Doherty, C M Buresh, et al.
Surgery|August 1, 1991
Pentoxifylline suppression of tumor necrosis factor gene transcriptionG M Doherty, J C Jensen, H R Alexander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic miceJ H Yim, S J Wu, M J Casey, et al.
Pageof 6